logo
#

Latest news with #Studio

‘The Studio' Emmy predictions: How many nominations can it get?
‘The Studio' Emmy predictions: How many nominations can it get?

Yahoo

time2 days ago

  • Entertainment
  • Yahoo

‘The Studio' Emmy predictions: How many nominations can it get?

Seth Rogen just might get to make a few acceptance speeches after all. While his on-camera doppelganger Matt Remick was desperate to be thanked from the Golden Globes stage, the cocreator/star/writer/director of Apple TV+'s The Studio may not have to worry. The freshman comedy may well prove to be the spoiler in the much-anticipated Emmys rematch between Hacks and The Bear — especially given its deep cast of A-list stars, the high-wire act of those oners, and Hollywood's love of celebrating itself. SEE'The Studio' episodes ranked, from worst to best With eight slots for best comedy, The Studio is assured of a nomination — the only question is whether it will unseat the reigning champ, Hacks. As of now The Studio is in second place on Gold Derby's predictions charts, but it's verrrrry close — and this time out, there's no debate about whether these contenders are comedies. Both bring on the laughs, both are a love letter to/satire of the industry, and both are undeniable hits. More from GoldDerby Kathryn Bigelow's Netflix Oscar hopeful gets explosive title: 'A House of Dynamite' Golden Globes set 2026 awards timeline, Best Podcast eligibility rules Jeremy Allen White is 'Born to Run' in the first trailer for Bruce Springsteen biopic 'Deliver Me From Nowhere' Apple With just 51 submissions, there are only five slots up for grabs, but Rogen is in solid second here, too — just behind SAG winner Martin Short. Either of them are likely going to eventually unseat two-time winner Jeremy Allen White — though the well-timed, though as yet-unseen-by-critics season four debut of The Bear on June 25 could prove a narrative shift for the FX series. But Rogen, who's been making the rounds on the FYC campaign trail, will undoubtedly hear his name called on July 15 for his bumbling, hapless studio executive. "It doesn't feel like I am having to shift gears between acting and writing and producing and directing," Rogen told Gold Derby. "As I'm acting, I'm also directing the scenes in a very subtle way, and I'm also rewriting the scene sometimes. And so to me, I actually think I feel the most comfortable when I'm doing all those things." SEESeth Rogen on taking big swings with 'The Studio': 'Are people just going to think this looks insane?' Who doesn't love Catherine O'Hara? She swept the TV awards cycle in 2020 for Schitt's Creek, and is a favorite among both audiences and her fellow actors. Which is why she's well-positioned for a double nomination this year — as supporting actress for The Studio, and for her guest turn on The Last of Us. (She can do drama! She can do comedy!) The only question is whether her costar and another potential double nominee can get in as well: Kathryn Hahn, who's in seventh place in our odds for supporting actress for The Studio as well as lead actress for Agatha All Along. Luckily, this category will have a deserving seven slots to fill, especially considering the competition from Hacks (Hannah Einbinder), The Bear (Liza Colon-Zayas), Abbott Elementary (Sheryl Lee Ralph, Janelle James), and Shrinking (Jessica Williams). (Costars Keyla Monterroso Mejia and Chase Sui Wonders were submitted in the category as well, but likely won't make the cut.) Apple TV+ Will we get to hear the magic words "Thank you, Sal Saperstein"? Ike Barinholtz stands in fourth place in our odds, comfortably secure in another seven-slot race; he, too, will have to fend off a two-time champion from The Bear, Ebon Moss-Bachrach, against the potential mid-summer momentum of Season 4. But the real surge may belong to Harrison Ford, another acting overachiever this season, who pulled double-duty with not only his well-hailed comedic turn in Shrinking but also weathered the winters of Taylor Sheridan's 1923 opposite another name familiar to award voters: Helen Mirren. The competition here also include Hacks star Paul W. Downs, Abbott Elementary's Tyler James Williams, and Ford's Shrinking costars Brett Goldstein and Michael Urie. SEE'Every actor likes to play a villain': Ron Howard on playing himself in 'The Studio' Apple TV+ Has one show ever swept an entire category? Unlikely, yes, but given The Studio's powerhouse lineup of cameos, it's not inconceivable that the majority of the six slots will go to at least two, if not three, of these names: Bryan Cranston, Martin Scorsese, Ron Howard, Dave Franco, David Krumholtz, Anthony Mackie, Nicholas Stoller, Zac Efron — and yes, Matt Belloni. (If only rival studio head Ted Sarandos had been submitted!) The race is Cranston's to lose — and Howard could even get nominated for playing himself twice. He's so good at playing himself, he did it also on Only Murders in the Building. 'I'm not quite that affable and fun-loving, nor am I the hard-ass in The Studio,' Howard told Gold Derby. 'I think I land somewhere in the middle.' Apple TV+ Name recognition always rules in this category, and The Studio's casting team worked their magic: Zoe Kravitz, Sarah Polley, Greta Lee, Olivia Wilde, and Rebecca Hall are all on the ballot. Currently ranked No. 7 in our prediction charts, Kravitz is the closest to breaking in to the magic six slots, with Polley and Wilde close behind. Years past have shown that single shows tend to sweep up the lion's share of nominations, so perhaps that will propel one or more of them to make the cut. But here again, they'll have to overtake buzzy performances from — you guessed it — Hacks (Julianne "Dance Mom" Nicholson) and The Bear (Jamie Lee Curtis). Not to mention Cynthia Erivo, who should get five slots alone for playing quintuplets on Poker Face. Apple Playing it safe — and strategic — The Studio submitted just one episode, "The Promotion," for writing, penned by Rogen, Evan Goldberg, Peter Huyck, Alex Gregory, and Frida Perez. It's the pilot that sets the tone, establishes the characters, and raises the stakes for the rest of the season — it's hard to imagine the show being nommed without the episode that put it on the map. As for the competition for the six slots, last season's winner, Hacks, too, also laid all its cards on just one episode: season 4's penultimate "A Slippery Slope," where all of the tensions that have been bubbling finally burst through. The Bear opted for two: "Napkins," Tina's backstory, and "Ice Chips," Natalie's labor episode. Strategy matters, here, too — and here again, The Studio went for its strongest directorial effort, "The Oner." Much ink, digital and otherwise, has been spilled over how the episode about a oner was shot as a oner, so suffice it to say that Rogen and Goldberg's directorial achievement here will not escape voters' notice. Vying for the other five slots: three episodes from The Bear which did earn two category noms last year and again, "A Slippery Slope" from Hacks. 'There were a few moments where I almost lost my mind, and then I reminded myself that I am the one who chose to do this,' Rogen said. 'Weird for me to get mad at someone for that. But it really was an amazing team effort.' SEESeth Rogen explains how 'The Studio' pulled off its one-shot episode But wait, there's more: With its intentionally retro feel, The Studio is a natural contender for production design, cinematography, casting, costumes, and even hairstyling. "Everyone else in the show is like a throwback and dresses in a nostalgic kind of way," Rogen said at the FYC panel for The Studio. "But the idea was that [Kathryn Hahn's character] would be on the crackling edge of fashion. ... The hair, though, became a whole thing I had nothing to do with. I just went along for the ride." Best of GoldDerby 'It was wonderful to be on that ride': Christian Slater talks his beloved roles, from cult classics ('Heathers,' 'True Romance') to TV hits ('Mr. Robot,' 'Dexter: Original Sin') Sam Rockwell on Frank's 'White Lotus' backstory, Woody Harrelson's influence, and going all in on 'this arc of Buddhist to Bad Lieutenant' Asif Ali and Saagar Shaikh admit they 'never had the audacity to realize' a show like 'Deli Boys' was possible Click here to read the full article.

Just one film studio gets ‘good' rating for LGBT+ representation
Just one film studio gets ‘good' rating for LGBT+ representation

The Independent

time12-06-2025

  • Entertainment
  • The Independent

Just one film studio gets ‘good' rating for LGBT+ representation

GLAAD 's 13th annual Studio Responsibility Index reveals a decline in LGBT+ representation in major studio film releases, dropping from 28.5 per cent in 2022 to 23.6 per cent in 2024. Transgender representation remains low, with only two 2024 films featuring trans characters and a decrease in screen time for LGBT+ characters overall. Racial diversity among LGBT+ characters in films has decreased to the lowest level since 2019. GLAAD President and CEO Sarah Kate Ellis said authentic LGBT+ representation in films is important as a means of visibility, especially amid political attacks. A24 was the only studio to receive a 'good' rating for LGBT+ inclusion, with 56 per cent of its films being LGBT+ inclusive, including titles like Queer and Love Lies Bleeding.

Spanish brand Desigual launches limited-edition Studio line, inspired by Barcelona
Spanish brand Desigual launches limited-edition Studio line, inspired by Barcelona

Fashion Network

time12-06-2025

  • Business
  • Fashion Network

Spanish brand Desigual launches limited-edition Studio line, inspired by Barcelona

Barcelona-based fashion brand Desigual is expanding its portfolio with a new premium line. On September 10, the company will unveil Studio, a limited-edition collection, with a dedicated runway show in its home city. 'With Studio, we want to showcase Desigual at its most extreme, in its purest expression. This first Studio FW25 (Fall/Winter 2025) collection draws inspiration from Barcelona—creative, ambitious and deeply rooted in our DNA. Studio allows us to reaffirm the brand's distinctive identity and to celebrate design in its highest form,' said the brand's product director, Fernanda Blasco. The new premium line reinterprets Desigual's signature codes, delivering a fresh aesthetic that reflects the brand's creative evolution. The collection features expressive and colorful pieces with a bold, feminine style, crafted from high-quality materials. The launch supports Desigual's ongoing transformation strategy, which aims to refresh and rejuvenate its image. Recent initiatives include a capsule collection with New York designer Tyler McGillivary and the appointment of Spanish actress Ester Expósito as the brand's new ambassador to attract a younger audience. Thomas Meyer founded the Barcelona-based company in 1984. Today, Desigual operates more than 280 standalone stores and is present in 107 markets worldwide through 10 sales channels. In fiscal year 2024, the company generated revenue of €332 million, driven primarily by growth in international sales and the strong performance of its online channel.

Medable launches programme to enhance eCOA build capabilities in clinical trials
Medable launches programme to enhance eCOA build capabilities in clinical trials

Yahoo

time11-06-2025

  • Business
  • Yahoo

Medable launches programme to enhance eCOA build capabilities in clinical trials

US-based clinical technology provider Medable has launched a programme to supply contract research organisations (CROs) with generative AI-driven, electronic clinical outcome assessment (eCOA) build capabilities in digitally enabled studies. The Partner Program runs on the company's platform and aims to enable CROs to reduce clinical trial timelines by at least 50%, providing both administrative and financial benefits. It is also designed to help CROs generate trial-specific quotes rapidly and enter trial kick-off or bid defence meetings with pre-built digital studies. The Partner Program offers CROs a choice between self-service, managed service, or a hybrid support model, with the aim to deliver higher margin services through the use of generative AI. Among the programme's features are tools for pricing, demo support for bid defence meetings, and a content library to facilitate reuse and scalability. One of its key components is access to Studio, Medable's AI-powered tool for creating, storing and reusing eCOA instruments. Studio is designed to allow CROs to build eCOA assessments and deploy trials independently, providing the flexibility they need to scale their operations. Its features include content libraries, a translational workbench, virtual scheduling capabilities, and an AI-based point-and-click builder. Medable chief customer officer Alison Holland said: 'We have created a better buyer experience for CROs while putting powerful generative AI capabilities into their hands to reduce the time to first-patient-in and ensure greater control over the trial build process. 'Medable's Partner Program also simplifies administration and delivers strategic business advantages. Sponsors will want to work with our partners to move closer to Medable's vision of a one-day study start.' Based in California, Medable offers a digital clinical trials platform that has been used in nearly 400 trials across 70 countries to date. The company recently launched a digital-first long-term follow-up model intended to reduce burdens on sites and participants in cell and gene therapy trials. "Medable launches programme to enhance eCOA build capabilities in clinical trials" was originally created and published by Clinical Trials Arena, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site.

Medable Launches Partner Program for Faster Clinical Trial Startup, Greater Control, and Transparent Pricing
Medable Launches Partner Program for Faster Clinical Trial Startup, Greater Control, and Transparent Pricing

Business Wire

time10-06-2025

  • Business
  • Business Wire

Medable Launches Partner Program for Faster Clinical Trial Startup, Greater Control, and Transparent Pricing

PALO ALTO, Calif.--(BUSINESS WIRE)-- Medable Inc., a leading provider of clinical development technology, today unveiled its new Partner Program, designed to empower contract research organizations (CROs) and other partners with generative AI-driven, self-service eCOA build capabilities for digitally enabled clinical trials. Leveraging the Medable platform, the program eliminates traditional bottlenecks for CROs to accelerate timelines by 50% or more, while delivering administrative and financial benefits, including straightforward, up-front pricing. Medable's Partner Program allows CROs to choose from three models – self-service, managed-service, or a hybrid of both support options. It offers pricing tools, demo support for bid defense meetings, and a portfolio content library to enable reuse and scale. The program provides partial or full enablement to help CROs take control and drive higher margin services, leveraging GenAI to help differentiate themselves in the market. Regardless of support options, the Medable Partner Program offers CROs a better, collaborative eCOA design experience for their sponsors with real-time updates. A major advantage of Medable's Partner Program is access to Studio, Medable's AI-powered solution for building, storing, and reusing eCOA instruments. Designed with CROs in mind, Studio enables self-service eCOA builds and trial deployments, giving CROs more control and flexibility to scale operations. Non-technical staff can easily build assessments in minutes for various studies and therapeutic areas with Medable Studio's rich content libraries, translational workbench, virtual scheduling, AI-based point-and-click builder, and user-friendly interface. In addition to the technical advantages of Medable Studio licensing, Medable's Partner Program simplifies the contractual relationship with upfront, consistent, and competitive pricing, streamlined communications, and on-demand support to reduce the need for change orders. The Medable Partner Program puts CROs in control to confidently: Leverage AI and automation to build higher-quality studies faster and more efficiently; Generate study-specific quotes in seconds using a self-serve pricing calculator; and, Enter any study kick-off or bid defense meeting with a pre-built digital study, ready for instant feedback and updates. 'We have created a better buyer experience for CROs while putting powerful generative AI capabilities into their hands to reduce the time to first-patient-in and ensure greater control over the trial build process,' said Alison Holland, Medable's Chief Customer Officer. 'Medable's Partner Program also simplifies administration and delivers strategic business advantages. Sponsors will want to work with our partners to move closer to Medable's vision of a one-day study start.' Medable has deployed its software-as-a-service platform in more than 300 decentralized and digitally enhanced clinical trials in 70 countries, serving more than one million patients and research participants globally. Customers have achieved impressive results – including 90% eCOA adherence and 50% cost reductions. A Tufts CSDD study also shows that, on average, decentralized trials can achieve net financial benefits from five to 13 times for Phase II and Phase III trials, equating to roughly $10 million ROI and $39 million ROI for an investment on average of $500K in Phase II and $1.5M in Phase III trials, respectively. Recently, the company launched Medable AI and Medable Studio to automatically convert outcomes assessments into fully digital eCOAs in seconds – now accessible on Google Cloud Marketplace. Today, eCOA is foundational to digitally enabled clinical trials. By leveraging Medable's AI-powered, SaaS model and new partnership efficiencies, CROs gain significant cost savings, speed, and scalability. About Medable Medable is on a mission to get effective therapies to people faster. Its digital clinical trials platform enhances speed, scale, and patient access in clinical research, accelerating medicines for thousands of conditions without treatment or cure. Awarded Best Digital Health Solution by the Galien Foundation, Medable's platform has been deployed in nearly 400 trials in 70 countries and 120 languages, serving more than one million patients globally. Medable is a privately held, venture-backed company headquartered in Palo Alto, California, and was listed for the second year in a row on the Inc. 5000 in 2024.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store